This HTML5 document contains 138 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
n12	http://dx.doi.org/10.1093/ANNONC/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
p	http://www.wikidata.org/prop/
wikibase	http://wikiba.se/ontology#
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n6	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q44177869

rdf:type

wikibase:Item

schema:description

2002年學術文章 2002年の論文 artículu científicu espublizáu en 2002 naučni članak научни чланак 2002年學術文章 научная статья مقالة علمية نشرت في أكتوبر 2002 scientific article published in October 2002 наукова стаття, опублікована в жовтні 2002 wetenschappelijk artikel სამეცნიერო სტატია artigo científico article scientifique 2002年學術文章 2002 nî lūn-bûn 2002年学术文章 articol științific 2002年学术文章 videnskabelig artikel научни чланак article scientific 2002年学术文章 tudományos cikk artículo científico publicado en 2002 επιστημονικό άρθρο artikulong pang-agham teaduslik artikkel мақолаи илмӣ artikel ilmiah научна статия article científic scientific article published in October 2002 bài báo khoa học vedecký článok scienca artikolo artigo científico 2002年學術文章 مقالة علمية تنشرت ف 1 أكتوبر 2002 wissenschaftlicher Artikel অক্টোবর ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vetenskaplig artikel artykuł naukowy vědecký článek vitenskapelig artikkel מאמר מדעי tieteellinen artikkeli 2002年学术文章 artikull shkencor articolo scientifico 2002年学术文章 2002年学术文章 scientific article published in October 2002 bilimsel makale 2002년 논문 2002年學術文章 artigo científico บทความทางวิทยาศาสตร์ vitskapeleg artikkel

p:P577

wds:Q44177869-F1F86AA0-EE8F-4B53-8B16-D6B69BFE1E58

wdt:P577

2002-10-01T00:00:00Z

p:P2860

wds:Q44177869-4B59FAED-EAB4-45AD-9AD7-DDCD89120800 wds:Q44177869-511722C4-44A6-4FA9-8CF5-D93B8D0A8CFD wds:Q44177869-58926EC6-14C9-4D6F-B300-47663425C9D9 wds:Q44177869-1EF2B322-2745-44EE-B1D3-B89EECC99EB8 wds:Q44177869-38F8725A-12DD-4314-92FE-EF8BE55D1B88 wds:Q44177869-683533EB-5315-4241-9162-26B608E3FD2E wds:Q44177869-6FA48BAF-95FA-4D53-B695-1D3A934FCAE6 wds:Q44177869-AF4150C1-4019-4A33-B092-AD6199F818E0 wds:Q44177869-949B0CFF-BDEE-4021-ABD7-B6FDCBFD06B9 wds:Q44177869-EF483AEC-31DD-4D35-994D-08FCAE8E2023 wds:Q44177869-FB80CCCE-F455-4C7A-940C-1B52CF03A40B

wdt:P2860

wd:Q33501101 wd:Q29620070 wd:Q43533552 wd:Q33341957 wd:Q48821076 wd:Q42641768 wd:Q34366342 wd:Q33388301 wd:Q42390593 wd:Q25938997 wd:Q54192267

p:P2093

wds:Q44177869-9244A722-999F-46F5-90F6-04379B36C3C6 wds:Q44177869-90D342EB-D080-45BA-BDAA-D0E17052F97F wds:Q44177869-B50A4FCC-3514-4923-9201-7C77FC702D44 wds:Q44177869-EE32768D-13CF-4606-AD4C-899AEB9A06EE wds:Q44177869-36A84900-A3A0-478D-A812-28EF11798CAE wds:Q44177869-3B4EF714-5D9C-4C74-9285-C26ABBBEFFC9 wds:Q44177869-8B9C9E60-A774-4E6E-92C0-E4EC5BA53037 wds:Q44177869-823D7D89-25D8-4D4D-AF5E-92F82D2EB2C4 wds:Q44177869-10C32E63-79EA-4EC4-A14C-A119096E8259 wds:Q44177869-0493EA8C-172A-4757-B429-FF5DDC1D6B5B

wdt:P2093

P Harper M Hill N Maisey N C Tebbutt M Seymour K Mochlinski T Hickish T Iveson Y Prior A Norman

rdfs:label

A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer

skos:prefLabel

A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer

schema:name

A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer

p:P50

wds:Q44177869-7BD616FA-353D-4D24-AA64-8A944FAD38D1

wdt:P50

wd:Q38803238

p:P1476

wds:Q44177869-BAA0BE02-0AC7-4BEF-9C26-5D4261914FB9

wdt:P1476

A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer

p:P304

wds:Q44177869-EB73CB3E-675E-4559-BEC8-DD4B79896176

wdt:P304

1568-1575

p:P31

wds:Q44177869-BA92C6D1-DFD1-4E97-8566-FD5971B68D07

wdt:P31

wd:Q13442814

p:P921

wds:Q44177869-8D8B9BE2-8D09-4038-9E05-10B2C555110E wds:Q44177869-9C6D6D25-70D3-4DE2-B06D-EDF96E637258 wds:Q44177869-81781472-5333-4C53-BB4D-E8B53EB35C3B

wdt:P921

wd:Q42824827 wd:Q6934595 wd:Q238512

p:P698

wds:Q44177869-0F928910-351E-4325-A1E3-E8A74E923C50

wdtn:P698

n6:12377644

wdt:P698

12377644

p:P1433

wds:Q44177869-F558CAF3-E979-4EF5-961B-FF0A4353B24A

wdt:P1433

wd:Q326122

p:P433

wds:Q44177869-37E2CB71-4719-4D49-9BCA-EB7B9B8AF44A

p:P478

wds:Q44177869-84355A75-E671-4EF4-9E42-583C73913F4A

wdt:P433

10

wdt:P478

13

p:P356

wds:Q44177869-BAE3ABD1-2B22-4D08-A355-80D75C6C23BF

wdtn:P356

n12:MDF273

wdt:P356

10.1093/ANNONC/MDF273

p:P5875

wds:Q44177869-7EA08503-2505-4085-AAB3-A16200B7B973

wdt:P5875

11081876